Dronabinol for Agitation in Dementia Crossover Trial

NCT05612711 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped Not funded

Conditions

Dementia Moderate
Dementia Severe
Agitation,Psychomotor
Behavioral Symptoms

Interventions

DRUG: Dronabinol

Sponsor

Ralph H. Johnson VA Medical Center

Collaborators

[object Object]